BenedictRHBAmatoMPDeLucaJ, et al. Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet Neurol2020; 19(10): 860–871.
2.
AmatoMPKruppLBCharvetLE, et al. Pediatric multiple sclerosis: Cognition and mood. Neurology2016; 87: S82–S87.
3.
RoccaMAAmatoMPDe StefanoN, et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol2015; 14(3): 302–317.
4.
MaineroCLouapreCGovindarajanST, et al. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain2015; 138(Pt. 4): 932–945.
5.
HerranzEGianniCLouapreC, et al. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol2016; 80(5): 776–790.
6.
BuyukturkogluKZengDBharadwajS, et al. Classifying multiple sclerosis patients on the basis of SDMT performance using machine learning. Mult Scler2021; 27: 107–116.
7.
SpeiserJLMillerMEToozeJ, et al. A comparison of random forest variable selection methods for classification prediction modeling. Expert Syst Appl2019; 134: 93–101.
8.
BenedictRHDeLucaJPhillipsG, et al. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler2017; 23(5): 721–733.
9.
LeavittVMTostoGRileyCS.Cognitive phenotypes in multiple sclerosis. J Neurol2018; 265: 562–566.
10.
De MeoERuanoLGorettiB, et al. Identifying distinct cognitive phenotypes in multiple sclerosis. Europ J Neurol2020; 78: 14306.
11.
SumowskiJFBenedictREnzingerC, et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology2018; 90: 278–288.
